Global DNA Diagnostics Market By Product Type (Instruments, Reagents, Service & Software), Application (Oncology, Infectious Disease Testing, Myogenic Disorder Diagnosis, Clinical Confirmation, Prenatal Diagnosis, Pre-implantation), Technology (PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry), End User
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the DNA Diagnostics Market
The global DNA Diagnostics Market Size is expected to reach $25,851.1 million by 2022, growing at a CAGR of 12.2% during 2016 -2022.
DNA diagnostics gained prominence due to the factors such as demand for effective treatment for chronic and infectious diseases, technological advancements in diagnostic techniques, and rapidly growing awareness about healthcare in the emerging markets. DNA diagnostics is being used in several applications due to its wide spectrum of applications such as in diagnosis of infectious diseases, oncologycancer, myogenic disorders, prenatal diagnostics, pre-implantation diagnostics, etc. DNA diagnostics product market is segmented into instruments, reagents, software and services.
The various types of instruments used are PCR, microarrays, sequencer, spectrometer etc. The instruments segment is the leading segment in the global DNA diagnostics product market. The rapid technological advances has led to the development of robust methodologies such as polymerase chain reaction (PCR), microarrays, gene sequencing and others. The aforementioned DNA based diagnostic methods facilitate the detection of mutations, identification of disease causing genes, and the diagnosis of myogenic disorders. The report highlights the adoption of DNA Diagnostics, globally.
Based on the Product Types, the Global DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).
Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.